In patients with diffuse large B-cell lymphoma, slan+CD16+ non-classical monocytes, but not CD14+ monocytes, increased and displayed highly efficient, rituximab-mediated, antibody-dependent cellular cytotoxicity, almost equivalent to that exerted by NK cells [43]. Here, CD14 is linked to diffuse large B-cell lymphoma.